Art

J-GLOBAL ID：201802252331464048   Reference number：18A0973891

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy

腫瘍壊死因子アルファ阻害剤はHTLV-I関連脊髄症患者由来のヒトT-lymphotropicウイルスI型(HTLV-I)感染細胞株に影響を及ぼさない【JST・京大機械翻訳】

Author (9)： Fukui Shoichi (Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Nakamura Hideki (Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Takahashi Yoshiko (Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Iwamoto Naoki (Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Hasegawa Hiroo (Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Yanagihara Katsunori (Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Nakamura Tatsufumi (Department of Human Community, Faculty of Social Welfare, Nagasaki International University, Sasebo, Japan) ,  Okayama Akihiko (Department of Rheumatology, Infectious Diseases and Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan) ,  Kawakami Atsushi (Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan)
Material： BMC Immunology (Web)
Volume： 18  Issue： 1  Page： 7  Publication year： 2017 
JST Material Number： U7306A  ISSN： 1471-2172  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Background While tumor necrosi...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0973891&from=J-GLOBAL&jstjournalNo=U7306A") }}

Thesaurus term： gene ,  infectious disease ,  apoptosis ,  time dependence ,  T cell ,  *infection ,  *human(primates) ,  TNF alpha ,  therapy ,  rheumatoid arthritis ,  chemokine ,  *HTLV1 ,  protein ,  *patient ,  in vitro experiment

Author keywords (5)： HTLV-I ,  TNF-α inhibitor ,  Cytokine ,  Chemokine ,  Proviral load

JST classification (1)： Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (39)：

• AIDS Res Hum Retrovir; An HTLV-I vaccine: why, how, for whom?; G de The, R Bomford; 9; 5; 1993; 381-386; 10.1089/aid.1993.9.381; CR1;
• Lancet Infect Dis; Human T-lymphotropic virus 1: recent knowledge about an ancient infection; K Verdonck, E Gonzalez, S Dooren; 7; 4; 2007; 266-281; 10.1016/S1473-3099(07)70081-6; CR2;
• J Acquir Immune Defic Syndr; The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I; JE Kaplan, M Osame, H Kubota; 3; 11; 1990; 1096-1101; CR3;
• N Engl J Med; A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis; JM Bathon, RW Martin, RM Fleischmann; 343; 22; 2000; 1586-1593; 10.1056/NEJM200011303432201; CR4;
• N Engl J Med; Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha; JD Gorman, KE Sack, JC Davis; 346; 18; 2002; 1349-1356; 10.1056/NEJMoa012664; CR5;

Terms in the title (8)： 腫瘍壊死因子アルファ阻害剤 ,  HTLV-I ,  脊髄症 ,  患者 ,  ヒト ,  ウイルス ,  感染 ,  細胞株